Legal & General Group Plc - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 69 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is 2.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$311,787
-1.8%
8,268
-1.3%
0.00%
Q2 2023$317,587
+94.0%
8,373
+24.4%
0.00%
Q1 2023$163,724
-16.3%
6,7320.0%0.00%
Q4 2022$195,498
+1.8%
6,732
+5.3%
0.00%
Q3 2022$192,000
-17.6%
6,393
-0.6%
0.00%
Q2 2022$233,000
-22.1%
6,433
-7.1%
0.00%
Q1 2022$299,000
+9.1%
6,923
+26.8%
0.00%
Q4 2021$274,000
-21.9%
5,459
-1.0%
0.00%
Q3 2021$351,000
-10.9%
5,515
+0.9%
0.00%
Q2 2021$394,000
-3.2%
5,465
-1.0%
0.00%
Q1 2021$407,000
-0.7%
5,520
-1.0%
0.00%
Q4 2020$410,000
+51.3%
5,578
+12.8%
0.00%
Q3 2020$271,000
-17.6%
4,944
-0.2%
0.00%
Q2 2020$329,000
+8.6%
4,9530.0%0.00%
Q1 2020$303,000
-30.5%
4,9530.0%0.00%
Q4 2019$436,000
+6.6%
4,953
-8.7%
0.00%
Q3 2019$409,000
-11.7%
5,4260.0%0.00%
Q2 2019$463,000
-21.0%
5,4260.0%0.00%
Q1 2019$586,000
+40.5%
5,426
+10.1%
0.00%
Q4 2018$417,000
+38.1%
4,930
+60.7%
0.00%
Q3 2018$302,000
-14.9%
3,0680.0%0.00%
Q2 2018$355,000
+5.0%
3,068
-10.3%
0.00%
Q1 2018$338,000
-3.4%
3,421
+2.4%
0.00%
Q4 2017$350,000
-68.7%
3,340
-66.3%
0.00%
-100.0%
Q3 2017$1,117,000
+19.8%
9,911
+19.2%
0.00%0.0%
Q2 2017$932,000
+0.5%
8,318
+4.7%
0.00%0.0%
Q1 2017$927,000
+12.6%
7,948
+1.7%
0.00%0.0%
Q4 2016$823,0007,8170.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Claret Asset Management Corp 86,474$6,524,0001.34%
Analyst IMS Investment Management Services Ltd. 28,438$2,143,0000.64%
ALGERT GLOBAL LLC 20,876$1,575,0000.59%
Quantinno Capital Management LP 9,351$706,0000.48%
Crestline Management, LP 37,000$2,792,0000.45%
Empirical Finance, LLC 9,561$721,0000.20%
BRANDES INVESTMENT PARTNERS, LP 55,065$5,469,0000.14%
FORT, L.P. 9,672$730,0000.14%
CAXTON ASSOCIATES LP 8,865$669,0000.13%
ACADIAN ASSET MANAGEMENT LLC 330,448$24,928,0000.11%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders